Patents by Inventor Andy Popplewell

Andy Popplewell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BINDING AGENTS
    Publication number: 20110097342
    Abstract: Compositions and methods relating to epitopes of sclerostin protein, and sclerostin binding agents, such as antibodies capable of binding to sclerostin, are provided.
    Type: Application
    Filed: November 19, 2010
    Publication date: April 28, 2011
    Applicants: AMGEN INC., UCB PHARMA S.A.
    Inventors: Christopher J. Paszty, Martyn K. Robinson, Kevin Graham, Alistair J. Henry, Kelly S. Warmington, John Latham, Hsieng S. Lu, Alastair Lawson, Andy Popplewell, Wenyan Shen, David G. Winkler, Aaron G. Winters
  • Sclerostin-binding antibodies
    Patent number: 7872106
    Abstract: Compositions and methods relating to epitopes of sclerostin protein, and sclerostin binding agents, such as antibodies capable of binding to sclerostin, are provided.
    Type: Grant
    Filed: November 24, 2008
    Date of Patent: January 18, 2011
    Assignees: Amgen Inc., UCB Pharma S.A.
    Inventors: Christopher J. Paszty, Martyn K. Robinson, Kevin Graham, Alistair J. Henry, Kelly S. Warmington, John Latham, Hsieng S. Lu, Alastair Lawson, Andy Popplewell, Wenyan Shen, David G. Winkler, Aaron G. Winters
  • ANTIBODY-BASED DIAGNOSTICS AND THERAPEUTICS
    Publication number: 20100036091
    Abstract: Compositions and methods relating to sclerostin binding agents, such as antibodies and polypeptides capable of binding to sclerostin, are provided.
    Type: Application
    Filed: November 9, 2007
    Publication date: February 11, 2010
    Applicants: AMGEN INC., UCB PHARMA S.A.
    Inventors: Martyn Kim Robinson, Christopher J. Paszty, Alastair James Henry, Alistair Lawson, Andy Popplewell
  • BINDING AGENTS
    Publication number: 20090304713
    Abstract: Compositions and methods relating to epitopes of sclerostin protein, and sclerostin binding agents, such as antibodies capable of binding to sclerostin, are provided.
    Type: Application
    Filed: November 24, 2008
    Publication date: December 10, 2009
    Applicants: AMGEN INC., UCB PHARMA S.A.
    Inventors: Christoper Paszty, Martin Kim Robinson, Kevin Graham, Alistair James Henry, Kelly Sue Hoffmann, John Latham, Hsieng Sen Lu, Alastair Lawson, Andy Popplewell, Wenyan Shen, David G. Winkler, Aaron George Winters
  • Sclerostin-binding antibody
    Patent number: 7592429
    Abstract: Compositions and methods relating to epitopes of sclerostin protein, and sclerostin binding agents, such as antibodies capable of binding to sclerostin, are provided.
    Type: Grant
    Filed: April 25, 2006
    Date of Patent: September 22, 2009
    Assignees: UCB SA, Amgen Inc.
    Inventors: Christopher Paszty, Martyn Kim Robinson, Kevin Graham, Alistair James Henry, Kelly Sue Hoffmann, John Latham, Hsieng Sen Lu, Alastair Lawson, Andy Popplewell, Wenyan Shen, David Winkler, Aaron George Winters
  • Binding agents
    Publication number: 20070110747
    Abstract: Compositions and methods relating to epitopes of sclerostin protein, and sclerostin binding agents, such as antibodies capable of binding to sclerostin, are provided.
    Type: Application
    Filed: April 25, 2006
    Publication date: May 17, 2007
    Applicants: UCB S.A., Amgen, Inc.
    Inventors: Christopher Paszty, Martyn Robinson, Kevin Graham, Alistair Henry, Kelly Hoffmann, John Latham, Hsieng Lu, Alastair Lawson, Andy Popplewell, Wenyan Shen, David Winkler, Aaron Winters